NASDAQ · SIEN
Sientra, Inc.
$0.17-$0.04 (-18.69%)
Sientra, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.48% below the high.
Loading market information…
NASDAQ · NAYA · USD
Stock price, earnings
Quote as of Apr 25, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NAYA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NAYA Biosciences, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:50 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $712.43K+58.32% vs estimate |
| Q1 2023 | May 15, 2023 | -$48.00-25.0% vs estimate | $646.71K+72.92% vs estimate |
|---|
| Q4 2022 | Dec 31, 2022 | -$1.14+97.51% vs estimate | $278.14K+8.02% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.17-$0.04 (-18.69%)
Sientra, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.48% below the high.
$0.10$0.00 (0.0%)
Cutera, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.77% below the high.
$0.42+$0.42 (+100.0%)
CareMax, Inc.’s quoted price sits in the lower half of its reported 52-week range, 18.94% below the high.
$0.53-$0.17 (-24.12%)
Oncternal Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.04% below the high.
$0.47-$0.12 (-20.74%)
Avinger, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.15% below the high.
$0.03$0.00 (0.0%)
Cassava Sciences, Inc. Warrant’s quoted price sits in the lower half of its reported 52-week range, 99.73% below the high.
$0.38-$0.01 (-1.56%)
NeuBase Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.49% below the high.
$0.34+$0.00 (+0.74%)
Timber Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.89% below the high.
